PREGRIO-250
Hydroxyprogesterone Caproate IP 250 mg Injection (with Sterile Dispo Pack & Alcohol Swab)
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | PREGRIO-250 |
| Active Formulation (Salt) | Hydroxyprogesterone Caproate IP 250 mg Injection (with Sterile Dispo Pack & Alcohol Swab) |
| Dosage Form | INJECTIONS |
| Packaging Presentation | Dispo (1 Ampoule of 1ml with Swab) |
| Therapeutic Category | INJECTIONS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is PREGRIO-250?
Therapeutic monograph and clinical profile
PREGRIO-250 (Hydroxyprogesterone Caproate IP 250 mg Injection (with Sterile Dispo Pack & Alcohol Swab)) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in Dispo (1 Ampoule of 1ml with Swab), it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Reduces Preterm Birth Risk / Supports Pregnancy Maintenance.
Key Formulation Highlights
Why healthcare professionals recommend PREGRIO-250
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Reduces Preterm Birth Risk / Supports Pregnancy Maintenance
Pharmacological Mechanism of Action
How PREGRIO-250 acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for PREGRIO-250
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for PREGRIO-250 across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding PREGRIO-250
What is PREGRIO-250 used for?
What is the active composition of PREGRIO-250?
How can I get monopoly PCD franchise for PREGRIO-250 in my district?
What is the packaging and MRP of PREGRIO-250?
Related Formulations in INJECTIONS
Explore complementary WHO-GMP certified healthcare formulations
